Working on both sides of the bench-to-bedside translation – turning biological discovery into patient care – is a privilege and my passion.
Where I see patients (3)
Selected research
-
Phase II Study of Ulixertinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Alterations: APEC1621J of the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial.
JCO precision oncology
-
The essential chaperone DNAJC17 activates HSP70 to coordinate RNA splicing and G2-M progression.
bioRxiv : the preprint server for biology
-
Clinical Targeted Next-Generation Panel Sequencing Reveals MYC Amplification Is a Poor Prognostic Factor in Osteosarcoma.
JCO precision oncology
Contact me
Learning never stops
Our classroom and bedside classes help kids get credit and keep learning during treatment.
See our school program